Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; polyvalent for multiple organisms, each polyvalent antiserum

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 87451 refers to a laboratory test designed to detect infectious agent antigens in blood and other body fluids through various immunoassay techniques. This code encompasses qualitative or semiquantitative testing methods, which include enzyme immunoassay (EIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and immunochemiluminometric assay (IMCA). These techniques utilize labeled antibodies that specifically bind to the target antigens present in the patient sample. The EIA and ELISA methods are particularly notable for their ability to detect minute quantities of antigens due to the use of a secondary enzyme-labeled antibody, which facilitates a chromogenic reaction resulting in a visible color change or fluorescence. This allows for the measurement of the infectious agent's presence in a qualitative or semiquantitative manner. The FIA method employs a fluorescent compound to indicate the binding of the detection antibody to the analyte, while the IMCA method utilizes a light emission device to quantify the antigen-antibody complex through chemiluminescence. It is important to note that code 87451 is specifically used for reporting polyvalent testing, which involves multiple organisms, with each polyvalent antiserum being utilized to identify serological subtypes of specific organisms that may have various strains present. For organisms that do not have a specific code for reporting, code 87449 should be used instead.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The CPT® Code 87451 is indicated for use in the detection of infectious agent antigens in various clinical scenarios. The following conditions may warrant the use of this testing method:

  • Infectious Disease Diagnosis The test is performed to identify the presence of specific infectious agents in patients exhibiting symptoms of infectious diseases.
  • Screening for Infections It is utilized as a screening tool for populations at risk of exposure to multiple infectious agents.
  • Monitoring Treatment Efficacy The test can be used to monitor the effectiveness of treatment in patients undergoing therapy for infectious diseases.
  • Public Health Surveillance It aids in public health efforts to track and control outbreaks of infectious diseases by identifying prevalent antigens in the community.

2. Procedure

The procedure for conducting the test under CPT® Code 87451 involves several key steps, which are outlined as follows:

  • Sample Collection A sample of blood or other body fluids is collected from the patient. This sample serves as the basis for the immunoassay testing.
  • Preparation of the Sample The collected sample is prepared for analysis, which may involve centrifugation or other methods to isolate the components necessary for testing.
  • Immunoassay Technique Application The prepared sample is subjected to one of the immunoassay techniques, such as EIA, ELISA, FIA, or IMCA. This involves adding specific antibodies that are labeled to bind to the target antigens present in the sample.
  • Detection and Measurement Following the binding of antibodies to antigens, the reaction is measured. For EIA and ELISA, a chromogenic reaction occurs, resulting in a color change that can be quantified. In FIA, fluorescence is measured, while IMCA utilizes light emission to quantify the antigen-antibody complex.
  • Result Interpretation The results are interpreted to determine the presence and quantity of the infectious agent antigens, providing qualitative or semiquantitative data based on the assay used.

3. Post-Procedure

After the completion of the testing procedure associated with CPT® Code 87451, the following post-procedure considerations are important:

Results are typically reviewed and interpreted by a qualified healthcare professional, who will communicate the findings to the patient or referring physician. Depending on the results, further diagnostic testing or treatment may be recommended. It is essential to ensure that the results are documented accurately in the patient's medical record for future reference and continuity of care. Additionally, any necessary follow-up actions, such as retesting or additional investigations, should be planned based on the findings of the immunoassay test.

Short Descr POLYVALENT MULT ORG EA AG IA
Medium Descr IAAD IA POLYV MLT ORGANISMS EA POLYV ANTISERUM
Long Descr Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; polyvalent for multiple organisms, each polyvalent antiserum
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
Date
Action
Notes
2022-01-01 Changed First appearance of change in codebook.
2022-01-01 Note Grammatical correction.
2021-01-01 Changed First appearance of change in CPT® Code Set.
2020-10-06 Changed Code description changed.
2016-01-01 Changed Description Changed
2011-01-01 Changed Short description changed.
2001-01-01 Added First appearance in code book in 2001.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"